Afternext Healthtech Acquisition Corp
NYSE:AFTR
ROE
Return on Equity
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
ROE Across Competitors
ROE Comparison
Afternext Healthtech Acquisition Corp Competitors
Country | US |
Market Cap | 325.3m USD |
ROE |
4%
|
Country | CA |
Market Cap | 576.3B CAD |
ROE |
-192%
|
Country | US |
Market Cap | 301B USD |
ROE | N/A |
Country | US |
Market Cap | 270.6B USD |
ROE |
3 074%
|
Country | NL |
Market Cap | 80.5B Zac |
ROE |
12%
|
Country | US |
Market Cap | 55.5B USD |
ROE | N/A |
Country | US |
Market Cap | 55.2B USD |
ROE |
-23%
|
Country | US |
Market Cap | 53.9B USD |
ROE |
76%
|
Country | ID |
Market Cap | 620.3T IDR |
ROE | N/A |
Country | US |
Market Cap | 38.4B USD |
ROE | N/A |
Country | US |
Market Cap | 29.3B USD |
ROE | N/A |
ROE Distribution
ROE Distribution
N/A Industry
Profitability Report
View the profitability report to see the full profitability analysis for Afternext Healthtech Acquisition Corp.
See Also
ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.
Based on Afternext Healthtech Acquisition Corp's most recent financial statements, the company has ROE of 3.7%.